“HealthEast Care System is dedicated to providing clinical excellence in the services that can improve patient health in the communities we serve,” said Brad Johnson, M.D., Senior Medical Director of HealthEast Care System.  “Our care providers specialize in family practice, internal medicine, OB/GYN and pediatrics.  Since cardiovascular disease continues to be the number one killer in the United States , we are taking a proactive role in the early detection of this devastating disease.  We feel that the CVProfilor^â will provide a non-invasive guide to the most appropriate early patient intervention,” added Dr. Johnson.

“HealthEast Care System is the first multi-clinic provider using the CVProfilor^® and their commitment to cardiovascular disease prevention is commendable.  Having this test available in a doctor’s office means that many more patients may benefit from the early detection of life threatening cardiovascular disease before they experience a heart attack or stroke,” said Greg H. Guettler, HDI’s President.

Hypertension Diagnostics, Inc. designs, develops, manufactures and markets proprietary cardiovascular profiling systems for medical applications and clinical research. These systems are marketed to physicians, other health care professionals and researchers by a direct sales force and via distributors throughout the world.  In addition to providing blood pressure values, the systems non-invasively detect subtle changes in the compliance or elasticity of both large and small arteries which is a unique feature of HDI’s technology.

Forward-looking statements in this press release are made under the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The Company wishes to caution readers not to place undue reliance on any forward-looking statements and to recognize that the statements are not a prediction of actual future results. Actual results could differ materially from those presented and anticipated in the forward-looking statements due to the risks and uncertainties set forth in the Company's 2000 Annual Report on Form 10-KSB, as amended, under the caption “Risk Factors,” as well as others not now anticipated.

Hypertension Diagnostics, HDI/PulseWave™ and CVProfilor^® are trademarks of Hypertension Diagnostics, Inc. All rights reserved.

Contact: Greg H. Guettler, President